Lau Associates’s Bristol-Myers Squibb BMY Stock Holding History

Lau Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,700	Closed	-$485K	–	76
2017 Q2	$485K	Sell	8,700 -566	-6%	-$30.8K	0.39%	57
2017 Q1	$504K	Hold	9,266	–	–	0.45%	56
2016 Q4	$542K	Hold	9,266	–	–	0.55%	48
2016 Q3	$500K	Buy	9,266 +368	+4%	+$23.6K	0.51%	50
2016 Q2	$654K	Sell	8,898 -182	-2%	-$12.9K	0.69%	44
2016 Q1	$580K	Hold	9,080	–	–	0.6%	44
2015 Q4	$625K	Hold	9,080	–	–	0.67%	39
2015 Q3	$538K	Hold	9,080	–	–	0.63%	41
2015 Q2	$604K	Hold	9,080	–	–	0.59%	40
2015 Q1	$586K	Sell	9,080 -132	-1%	-$8.26K	0.56%	39
2014 Q4	$544K	Sell	9,212 -70	-0.8%	-$3.95K	0.5%	42
2014 Q3	$475K	Hold	9,282	–	–	0.44%	43
2014 Q2	$450K	Hold	9,282	–	–	0.41%	45
2014 Q1	$482K	Sell	9,282 -2,650	-22%	-$141K	0.43%	44
2013 Q4	$634K	Hold	11,932	–	–	0.56%	35
2013 Q3	$552K	Sell	11,932 -500	-4%	-$21.9K	0.46%	37
2013 Q2	$556K	Buy	+12,432	New	+$540K	0.47%	39

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lau Associates's BMY Position: Q3 2017 in Review

Lau Associates sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 8,700 shares — an estimated $485K sold.

Lau Associates first reported a position in BMY in Q2 2013 and held it in 17 quarters. The position peaked at $654K in Q2 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

Lau Associates reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
Lau Associates sold 8,700 Bristol-Myers Squibb shares in Q3 2017, an estimated $485K.
Lau Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 17 quarters.
Lau Associates's Bristol-Myers Squibb position peaked at $654K in Q2 2016.
1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Lau Associates's 13F filing for Q3 2017, filed 10 Oct 2017.